Gufic BioSciences Ltd. Investor Presentation

Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find attached herewith the Investor Presentation on Unaudited Financial Results of the Company for the quarter and half year ended September 30, 2023.

pdf

Gufic BioSciences Ltd.

11 Aug 2023

370.40

3.70%

Investor Presentation

GUFIC BIOSCIENCES LTD. - 509079 - Announcement under Regulation 30 (LODR)-Investor Presentation

BSE India

Pursuant to Regulation 30 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed herewith the Investor Presentation on Unaudited Financial Results of the Company for the Quarter ended June 30, 2023.

pdf

Gufic BioSciences Ltd.

29 May 2023

370.40

3.70%

Investor Presentation

GUFIC BIOSCIENCES LTD. - 509079 - Announcement under Regulation 30 (LODR)-Investor Presentation

BSE India

Pursuant to Regulation 30 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed herewith the Investor Presentation on Audited Financial Results of the Company for the quarter and financial year ended March 31, 2023

pdf

Gufic BioSciences Ltd.

11 Nov 2022

370.40

3.70%

Investor Presentation

GUFIC BIOSCIENCES LTD. - 509079 - Announcement under Regulation 30 (LODR)-Investor Presentation

BSE India

Pursuant to Regulation 30 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed herewith the Investor Presentation on Un-Audited Financial Results for the quarter and half year ended September 30, 2022.

pdf

Gufic BioSciences Ltd.

11 Aug 2022

370.40

3.70%

Investor Presentation

GUFIC BIOSCIENCES LTD. - 509079 - Announcement under Regulation 30 (LODR)-Investor Presentation

BSE India

Pursuant to Regulation 30 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed herewith the Investor Presentation on Financial Results for the quarter ended June 30, 2022. Kindly take the same on record.

pdf

Gufic BioSciences Ltd. Investor Presentation

Gufic BioSciences Ltd. Investor Presentation: Get insights into company performance, financials, capex plans and more